STOCK TITAN

Enova (NYSE: ENVA) executive chair sells 10,256 shares after exercising options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enova International Executive Chairman David Fisher reported option exercises paired with share sales. On May 21–22, 2026, he exercised options for 10,256 shares of common stock at an exercise price of $20.73 per share and sold the same number of shares in open-market transactions.

The reported weighted average sale prices were $160.3724 and $158.4467 per share across multiple trades. Following these transactions, Fisher directly holds 306,444 shares of Enova common stock, indicating he retained a substantial equity position after this exercise-and-sell activity.

Positive

  • None.

Negative

  • None.
Insider Fisher David
Role Executive Chairman
Sold 10,256 shs ($1.64M)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) with limited SAR 3,076 $0.00 --
Exercise Common stock, par value $0.00001 per share 3,076 $20.73 $64K
Sale Common stock, par value $0.00001 per share 3,076 $158.4467 $487K
Exercise Non-Qualified Stock Option (right to buy) with limited SAR 7,180 $0.00 --
Exercise Common stock, par value $0.00001 per share 7,180 $20.73 $149K
Sale Common stock, par value $0.00001 per share 7,180 $160.3724 $1.15M
Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 246,242 shares (Direct, null); Common stock, par value $0.00001 per share — 309,520 shares (Direct, null)
Footnotes (1)
  1. This transaction was executed in multiple trades at prices ranging from $158.16 to $162.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $157.50 to $161.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Shares sold 10,256 shares Total open-market sales on May 21–22, 2026
Sale price May 21 $160.3724 per share Weighted average price for 7,180 shares sold
Sale price May 22 $158.4467 per share Weighted average price for 3,076 shares sold
Option exercise price $20.73 per share Non-qualified stock options exercised for 10,256 shares
Post-transaction holdings 306,444 shares Direct Enova common stock held after transactions
Derivative exercises 2 transactions, 10,256 shares Option exercises classified as derivative transactions
Option expiration date February 11, 2027 Expiration of related non-qualified stock options
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with limited SAR"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
stock appreciation right ("SAR") financial
"The limited stock appreciation right ("SAR") and employee stock option were granted in tandem."
Change in Control financial
"The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Offer Value Per Share financial
"The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days"
tender offer or exchange offer financial
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fisher David

(Last)(First)(Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600

(Street)
CHICAGO ILLINOIS 60604

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Executive Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.00001 per share05/21/2026M7,180A$20.73313,624D
Common stock, par value $0.00001 per share05/21/2026S7,180D$160.3724(1)306,444D
Common stock, par value $0.00001 per share05/22/2026M3,076A$20.73309,520D
Common stock, par value $0.00001 per share05/22/2026S3,076D$158.4467(2)306,444D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(3)(4)$20.7305/21/2026M7,180 (5)02/11/2027Common stock; par value $0.00001 per share7,180$0249,318D
Non-Qualified Stock Option (right to buy) with limited SAR(3)(4)$20.7305/22/2026M3,076 (5)02/11/2027Common stock; par value $0.00001 per share3,076$0246,242D
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $158.16 to $162.90. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
2. This transaction was executed in multiple trades at prices ranging from $157.50 to $161.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
3. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
4. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
5. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
/s/ Sean Rahilly, as attorney in fact05/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Enova (ENVA) Executive Chairman David Fisher report?

David Fisher reported exercising stock options for 10,256 Enova shares and selling the same 10,256 shares in open-market transactions, combining derivative exercises with immediate share sales while still retaining a sizable direct holding in the company.

How many Enova (ENVA) shares did David Fisher sell and at what prices?

David Fisher sold 10,256 Enova common shares in total. Weighted average sale prices were about $160.3724 per share on May 21, 2026 and $158.4467 per share on May 22, 2026, across multiple individual trades each day.

What option exercise price applied to David Fisher’s Enova (ENVA) transactions?

The exercised non-qualified stock options for Enova shares carried an exercise price of $20.73 per share. Fisher exercised 10,256 option shares at this price before selling an equal number of common shares in the open market on consecutive days.

How many Enova (ENVA) shares does David Fisher own after these transactions?

After the reported option exercises and open-market sales, David Fisher directly holds 306,444 shares of Enova common stock. This post-transaction figure shows he continues to maintain a significant ownership stake in the company despite the recent share sales.

Were David Fisher’s Enova (ENVA) stock sales single trades or multiple trades?

The reported Enova stock sales were executed through multiple trades each day within specified price ranges. The Form 4 discloses weighted average prices and notes that detailed trade-level data will be provided to the SEC, the company, or shareholders upon request.

What are the key terms of David Fisher’s Enova (ENVA) stock options and SARs?

Fisher’s non-qualified stock options were granted in tandem with a limited stock appreciation right (SAR). Exercising one causes the other to expire. The options vested in three equal annual installments beginning February 11, 2021, and are scheduled to expire on February 11, 2027.